Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies.

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Hemoglobin (Hb) is essential for tissue oxygenation, with its structure and expression tightly regulated throughout development.
• Mutations in hemoglobin genes cause hemoglobinopathies, a prevalent group of genetic disorders worldwide.
• Recent research has elucidated mechanisms controlling globin gene expression and identified protective genetic traits.

Purpose of the Study:

• To describe the developmental switch in globin gene expression.
• To highlight therapeutic strategies targeting globin gene regulation for hemoglobinopathies.

Main Methods:

• Review of existing literature on globin gene regulation during development.
• Analysis of findings from genome-wide association studies on protective genetic traits.
• Exploration of therapeutic approaches involving genome and epigenome modification.

Main Results:

• Detailed description of the key steps controlling globin gene expression shifts during development.
• Identification of protective genetic traits that can ameliorate hemoglobinopathy symptoms.
• Advancement in therapeutic strategies for hemoglobinopathies through gene/epigenome editing.

Conclusions:

• Understanding globin gene regulation is key to developing effective treatments for hemoglobinopathies.
• Targeting gene expression and leveraging protective traits represent promising therapeutic avenues.
• Innovative genome and epigenome-based therapies are emerging for hemoglobinopathies.